Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01262
|
|||||
Drug Name |
Actinomycin D
|
|||||
Synonyms |
AC1O8OFK; CCG-35952; CCG-36086; NCIMech_000599
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Ovarian cancer [ICD11: 2C73] | Approved | [1] | |||
Ewing's sarcoma [ICD11: 2B52] | Approved | [1] | ||||
Testicular cancer [ICD11: 2C80] | Approved | [1] | ||||
Wilms tumor [ICD11: 2C90.Y] | Approved | [1] | ||||
Trophoblastic neoplasm [ICD11: 2C75.0] | Approved | [1] | ||||
Rhabdomyosarcoma [ICD11: 2B55] | Approved | [1] | ||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C62H86N12O16
|
|||||
Canonical SMILES |
CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C
|
|||||
InChI |
InChI=1S/C62H86N12O16/c1-27(2)42-59(84)73-23-17-19-36(73)57(82)69(13)25-38(75)71(15)48(29(5)6)61(86)88-33(11)44(55(80)65-42)67-53(78)35-22-21-31(9)51-46(35)64-47-40(41(63)50(77)32(10)52(47)90-51)54(79)68-45-34(12)89-62(87)49(30(7)8)72(16)39(76)26-70(14)58(83)37-20-18-24-74(37)60(85)43(28(3)4)66-56(45)81/h21-22,27-30,33-34,36-37,42-45,48-49H,17-20,23-26,63H2,1-16H3,(H,65,80)(H,66,81)(H,67,78)(H,68,79)/t33-,34-,36+,37+,42+,43+,44-,45-,48-,49-/m1/s1
|
|||||
InChIKey |
RJURFGZVJUQBHK-ZXDIMXNISA-N
|
|||||
CAS Number |
CAS 50-76-0
|
|||||
Pharmaceutical Properties | Molecular Weight | 1255.4 | Topological Polar Surface Area | 356 | ||
Heavy Atom Count | 90 | Rotatable Bond Count | 8 | |||
Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 18 | |||
XLogP |
3.8
|
|||||
PubChem CID | ||||||
PubChem SID | ||||||
ChEBI ID |
ChEBI:27666
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Actinomycin D was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.